"Myristic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed)
Concept/Terms
Myristic Acid- Myristic Acid
- Acid, Myristic
- Tetradecanoic Acid
- Acid, Tetradecanoic
Below are MeSH descriptors whose meaning is more general than "Myristic Acid".
Below are MeSH descriptors whose meaning is more specific than "Myristic Acid".
This graph shows the total number of publications written about "Myristic Acid" by people in Harvard Catalyst Profiles by year, and whether "Myristic Acid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 6 | 6 |
| 1997 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2007 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 2 | 2 |
Below are the most recent publications written about "Myristic Acid" by people in Profiles.
-
NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle. Nat Commun. 2020 02 26; 11(1):1067.
-
A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation. Science. 2019 07 05; 365(6448).
-
Circulating Saturated Fatty Acids and Incident Type 2 Diabetes: A Systematic Review and Meta-Analysis. Nutrients. 2019 May 01; 11(5).
-
HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting. J Mol Biol. 2018 07 06; 430(14):2113-2127.
-
c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution. Biochemistry. 2016 06 14; 55(23):3251-60.
-
Discovery of allosteric BCR-ABL inhibitors from phenotypic screen to clinical candidate. Methods Enzymol. 2014; 548:173-88.
-
Structure and dynamic regulation of Abl kinases. J Biol Chem. 2013 Feb 22; 288(8):5443-50.
-
Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors. J Biol Chem. 2013 Mar 01; 288(9):6116-29.
-
Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulation. PLoS One. 2012; 7(7):e41330.
-
Effects of HIV-1 Nef on human N-myristoyltransferase 1. Biochemistry. 2011 Apr 26; 50(16):3394-403.